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Treatment of rats or liver homogenates with catecholamines (isoproterenol rnoradrenaline) increased acti- 
vities of both NAD+-dependent isocitrate dehydrogenase and NAD(P)+-transhydrogenase (in the direction 
of hydrogen transfer NADPH + NAD+) with no change in NADP+-dependent isocitrate dehydrogenase. 
These effects were realized via a-adrenoceptors. Cyclic AMP mimicked the catecholamine action on incuba- 
tion with liver homogenate. The effects of catecholamines and cyclic AMP were not additive. 
Catecholamine Adrenoceptor Cyclic AMP Mitochondria NAD(P)+-dependent isocitrate dehydrogenase 
NAD(P) +-transhydrogenase 
1. INTRODUCTION 
During the last decade the existence of catechol- 
amine control of liver mitochondrial function 
[l-S], including the stimulation of mouse-liver 
NAD+-dependent isocitrate dehydrogenase [2], 
was firmly recognized. However, problems related 
to the point(s) and mechanism of catecholamine 
action on mitochondrial metabolism are far from 
solved. It has been accepted and well documented 
that isocitrate oxidation can proceed within mito- 
chondria in two pathways: (i) via NAD+- 
dependent isocitrate dehydrogenase (EC 1.1.1.41); 
(ii) via NADP+-dependent isocitrate dehydro- 
genase (EC 1.1.1.42) coupled with NAD(P)+- 
transhydrogenase (EC 161.1): 
peritoneally). Phenylephrine (10 mg/kg) or iso- 
proterenol(2.3 mg/kg) was injected subcutaneous- 
ly 15 and 6 min, respectively, before killing. Nor- 
adrenaline (1 FM) was incubated with 10% (w/v) 
liver homogenate for 10 min at 30°C in the 
presence of 1 mM theophylline and 1 mM ascor- 
bate. Cyclic AMP (1 PM) was incubated under 
similar conditions but without ascorbate. There- 
after homogenates were cooled in ice and mito- 
chondria were prepared according to [l l] in 0.25 
M sucrose, 1 mM EDTA, 10 mM Tris-HCl buffer 
(pH 7.4). 
NADPH + NAD+ = NADP+ + NADH [g-lo]. 
We found that catecholamine controls both path- 
ways of isocitrate oxidation in rat liver 
mitochondria. 
The final mitochondrial pellet was lysed by the 
addition of 1% Triton X-100 and, after 20 min 
storage in ice, centrifuged at 18 000 x g for 20 min. 
The supernatant was used for the measurement of 
enzymes activities: NAD+- and NADP+-dependent 
isocitrate dehydrogenases [ 12,131 and NAD(P)+- 
transhydrogenase [ 141. Protein was determined by 
a modified Lowry method [15]. The activities of 
the enzymes were expressed as nmol NAD(P)H/ 
min per mg protein. 
2. MATERIALS AND METHODS 
Male Wistar rats (150-200 g) were anesthetised 
with sodium thiopental (100 mg/kg body wt intra- 
3. RESULTS 
Administration of ar-adrenoceptor agonist 
phenylephrine increased neither the activities of 
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NAD+- and NADP+-dependent isocitrate de- 
hydrogenases nor that of NAD(P)+-transhydro- 
genase (P> 0.3-0.6, not shown). Treatment of 
animals with the /?-adrenergic agonist iso- 
proterenol leads to marked stimulation of 
NAD+-dependent isocitrate dehydrogenase and 
NAD(P)+-transhydrogenase without any change in 
the activity of NADP+-dependent isocitrate de- 
hydrogenase (table 1). 
The increased activities of both NAD+- 
dependent isocitrate dehydrogenase and NAD(P)+- 
Table 1 
Effect of isoproterenol administration to rat on the ac- 
tivities of enzymes involved in isocitrate oxidation of 
liver mitochondria 
Series NAD+- NADP+- NAD(P)+- 
dependent dependent transhydro- 
isocitrate dehydro- genase 
genase 
Control 11.4 -+ 0.9 68.3 k 5.4 12.3 + 0.9 
1(4n6=*?7 7&L? 1 
(n = 11) 
Isoproterenol 
(n = 10; (i = 5; 
17.2 + 1.1 
(n = 11) 
P < 0.01 > 0.6 < 0.001 
Experimental conditions are described in section 2. Con- 
centration of substrate for each reaction: (a) for NAD+- 
dependent isocitrate dehydrogenase - 2 mM NAD+, 4 
mM isocitrate, 1 mM MnS04; (b) for NADP+- 
dependent isocitrate dehydrogenase - 0.5 mM NADP+, 
0.5 mM isocitrate, 8 mM MgC12; (c) for NAD(P)+-trans- 
hydrogenase - 1 mM NAD+, 0.25 mM NADPH and 
regenerating system: 2 mM isocitrate, 300 munits 
NADP+-dependent isocitrate dehydrogenase, 3 mM 
MgClz. In all experiments 1 mM KCN was used. Series 
were compared using Student’s t-test 
transhydrogenase were also observed in vitro after 
the incubation of noradrenaline with liver 
homogenate (table 2). It should be noted that 
stimulation of these enzymes in vivo and in vitro 
by catecholamines occurred to the same extent. 
Pretreatment of liver homogenate with the ,&- 
adrenoceptor antagonist propranolol but not with 
the a-adrenoceptor antagonist phentolamine com- 
pletely prevented noradrenaline action on 
NAD(P)+-transhydrogenase (table 3). Similar 
results were obtained for the catecholamine 
stimulation of NAD+-dependent isocitrate de- 
hydrogenase (not shown). 
Cyclic AMP incubation with liver homogenate 
mimicked the effect of the P-adrenergic agonists 
on the activities of both enzymes (table 4). Cyclic 
AMP action was highly specific: other adenine 
Table 2 
Influence of incubation of noradrenaline with liver 
homogenate on the activities of isocitrate dehydro- 
genases and NAD(P)+-transhydrogenase of rat liver 
mitochondria 
Series NAD+- NADP+- NAD(P)+- 
dependent dependent ranshydro- 
isocitrate dehydro- genase 
genase 
Control 10.8 + 0.8 70.1 f 4.3 13.1 f 1.4 
(n = 8) (n = 5) (n = 6) 
Noradrenaline 13.3 k 1.2 69.6 f 1.9 20.2 * 0.7 
(n = 8) (n = 5) (n = 6) 
P < 0.01 > 0.9 < 0.001 
All experimental conditions are described in section 2 
and table 1, except that MnS04 was substituted by 
MgCl2 (8 mM) in the assay medium for NAD+- 
dependent isocitrate dehydrogenase 
Table 3 
Effects of adrenoceptor antagonists on the stimulatory action of noradrenaline on NAD(P)+-trans- 
hydrogenase activity 
Series - Phentolamine + Phentolamine - Propranolol + Propranolol 
(10 PM) (10 FM) 
Control 8.2 k 0.6 7.6 f 0.9 10.3 f 1.0 10.7 f 1.2 
Noradrenaline 12.3 f 0.8 11.5 f 1.1 16.5 + 1.1 10.9 f 0.7 
P < 0.01 < 0.02 < 0.01 > 0.8 
The adrenoceptor antagonists were added to the homogenate 10 min before noradrenaline. In each 
series n = 7-8 
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Table 4 
Effect of the incubation of cyclic AMP with liver 
homogenate on the activities of mitochondrial isocitrate 
dehydrogenase and NAD(P)+-transhydrogenase 
Series NAD+- NADP+- NAD(P)+- 
dependent dependent transhydro- 
isocitrate dehydro- genase 
genase 
Control 11.8 + 0.8 88.8 1- 6.2 14.4 * 1.7 
(n = 11) (n = 10) (n = 6) 
Cyclic AMP 14.6 f 1.1 91.8 f 6.9 20.9 f 1.9 
P < 0.01 > 0.6 < 0.001 
Incubation conditions of cyclic AMP with liver 
homogenate are described in section 2 
nucleotides (5 ’ -AMP, ADP, ATP, 2’ ,3 ’ -AMP) 
and adenosine at the same concentration (1 PM) 
stimulated neither NAD+-dependent isocitrate de- 
hydrogenase (P> 0.7) nor NAD(P)+-transhydro- 
genase (P> 0.2-0.7). The effects of noradrenaline 
and cyclic AMP were not additive when both were 
applied to liver homogenate (P> 0.3-0.9). 
Summarizing the above results we may conclude 
that the stimulation of both enzyme activities by 
catecholamines occurs via a ,8-adrenergic cyclic 
AMP-dependent mechanism. 
4. DISCUSSION 
The altered activities of NAD+-dependent iso- 
citrate dehydrogenase and NAD(P)+-transhydro- 
genase after catecholamine injection or its incuba- 
tion with liver homogenate were observed in Triton 
X-100 mitochondrial extracts under saturating 
concentrations of substrates. This implies that the 
hormone stimulation of these enzymes is probably 
connected with changes in the catalytic properties 
themselves. Authors in [16] came to the same con- 
clusion when they found stimulation of succinate 
dehydrogenase in mitochondrial extracts after 
treating a rat with glucagon. 
The participation of NADP+-dependent iso- 
citrate dehydrogenase in the Krebs cycle is deter- 
mined by NAD(P)+-transhydrogenase [9, lo]. 
Thus, there is evidence that catecholamines act on- 
ly on the activities of the rate-limiting enzymes of 
both pathways of isocitrate oxidation: i.e., 
NAD+-dependent isocitrate dehydrogenase and 
NAD(P)+-transhydrogenase. However, the impor- 
tance of NAD(P)+-transhydrogenase (in the direc- 
tion NADPH + NAD+) is also connected with the 
ability of this enzyme to function as an energy 
generator [ 17- 191. Therefore, it seems reasonable 
to propose that not only the Krebs cycle enzymes 
but also coupling processes in mitochondria may 
be involved in the ‘sphere’ of catecholamine 
control. 
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